NLS Pharmaceutics AG

NLSPNASDAQHealthcare

$2.91

$-0.42(-12.61%)

Market Cap$919601

P/E Ratio—

52W High$43.4

52W Low$0.76

Avg Volume75K

Open$3.31

Beta0.13

Employees Ownership Insider Trades

NLS Pharmaceutics AG (NLSP) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · NLSP · as of Apr 29, 2026

Latest filing snapshot

3,500

-196,500-98.25%vs prior year

NLS Pharmaceutics AG (NLSP) employee data is sourced from the annual SEC 20-F filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2025-12-31·Full-time · Global

Total Employees

3,500

Change (1Y)

-196,500

Growth % (1Y)

-98.25%

Revenue / Employee

—

Net Income / Employee

$-566

Market Cap

$1M

NLSP Employee Count

2020 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-04-29	2025-12-31	3,500	-196,500	-98.25%
2025-05-16	2024-12-31	200,000	+0	+0.00%
2024-05-15	2023-12-31	200,000	+0	+0.00%
2023-05-05	2022-12-31	200,000	+0	+0.00%
2022-03-24	2021-12-31	200,000	+0	+0.00%
2021-05-14	2020-12-31	200,000	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

NLSP

NLS Pharmaceutics AGYOU

BriaCell Therapeutics Corp.

CERo Therapeutics Holdings, Inc.

8$0M #7

KTTA

Pasithea Therapeutics Corp.

4$4M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · NLSP peer comparison

About NLSP employees

NLSP Employees · Headcount

NLS Pharmaceutics AG (NLSP) employee data is sourced from the annual SEC 20-F filing. As of 2025, NLS Pharmaceutics AG had 3,500 full-time employees globally. Full-time employees only. Global consolidated headcount.

NLS Pharmaceutics AG's workforce decreased by 196,500 (98.25%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

NLSP Employees · 5 questions

As of the latest SEC 20-F filing (2025), NLS Pharmaceutics AG had 3,500 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

NLS Pharmaceutics AG employee counthow many employees does NLS Pharmaceutics AG haveNLSP total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-04-29